With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing||University of Massachusetts Medical School / Peter Newburger, M.D.||Innovation Grants||2014||Massachusetts|
|Mechanisms of LGR5 Regulation and Function in Ewing sarcoma Metastasis||University of Michigan / Elizabeth Lawlor, M.D., Ph.D.||Innovation Grants||2014||Michigan|
|Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer||Baylor College of Medicine / Stephen Gottschalk, M.D.||Innovation Grants||2014||Texas|
|Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype||The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D.||Innovation Grants||2014||Maryland|
|Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit||University of Colorado Denver / Patricia Ernst, Ph.D.||Innovation Grants||2014||Colorado|
|Targeting the Accomplices of MYC in MYC-driven Medulloblastoma||Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D.||Innovation Grants||2014||California|
|Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, M.D.||Innovation Grants||2014||Maryland|
|Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma||Dana-Farber Cancer Institute / Thomas Look, M.D.||Innovation Grants||2014||Massachusetts|
|Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering||Massachusetts General Hospital / Hanno Hock, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells||University of Florida / Steven Ghivizzani, Ph.D.||Innovation Grants||2014||Florida|